New Delhi, Dec 12
Sun Pharma said on Thursday that it has received US health regulator’s nod to market a generic version of Eli Lilly & Company’s Cymbalta, an anti-depressant drug, in the American market.»
December 7, 2013
With robust growth drivers in place, the stock of Sun Pharma looks interesting at present given the 11 per cent correction in the price over the last two months. Healthy growth in key markets –...
November 23, 2013
I am holding shares of Ceat bought at an average price of Rs 98. I am a long term investor. Please suggest whether I should book profits at current level or hold for further gains in the next coup...
November 14, 2013
Price increases on select drugs in the US by its subsidiary Taro Pharma and sharp depreciation of rupee against dollar led to a 51 per cent jump in Sun Pharma’s adjusted profit. <...
New Delhi, Nov 14
Drug-maker Sun Pharmaceutical Industries Ltd has upped its growth projection for the current fiscal to 25 per cent, on the back of a healthy performance in the first six months, Dilip Shanghvi, Ma...
Chennai, Nov 12
Sun Pharmaceuticals retreated from its morning highs on the BSE on Tuesday. At 2.50 p.m. it was quoting at Rs 599.50 or 0.44 per cent higher than its previous close of Rs 596.90. ...
Chennai, Nov 6
Sun Pharma was firm but off its earlier highs on the bourses on Wednesday. At 3 p.m. it was quoting at Rs 603.90, a gain of 1.88 per cent on Tuesday’s close of Rs 592.75. On the NSE it w...
New Delhi, Oct 28
As the US intensifies its scrutiny of drug companies, Sun Pharma said it too had faced minor queries from that nation’s Food and Drug Administration (FDA).
“These were minor observations,...
October 3, 2013
Sun Pharmaceutical Industries Ltd has submitted to BSE a copy of the report of the proceedings of the 21st Annual General Meeting (AGM) of the Company held on September 30, 2013.
Source : BS...
Mumbai, Oct. 1
Drug-maker Sun Pharmaceutical and US-based Intrexon Corporation have entered into an alliance to develop controllable gene-based therapies for the treatment of eye-related diseases that cause part...
December 12, 2013
Sun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release dated December 12, 2013 titled, "Sun Pharma announces US FDA approval for generic Cymbalta®"
Source : BSE - <...
Chennai, Dec 2
Sun Pharma extended its morning gains towards close on Monday. At 3.05 p.m. it was quoting at Rs 594.90 on the BSE, up 3.98 per cent on its previous close of Rs 572.15. On the NSE it quo...
November 16, 2013
The State Bank of India’s profits declined 35 per cent to Rs 2,375 crore for the September quarter compared to a year ago. The company’s loan growth was 19 per cent, a tad higher than larg...
November 14, 2013
Sun Pharmaceutical Industries Ltd has submitted to BSE a copy of Press Release relating to second quarter FY14 & first half FY14 financials.
Source : BSE - »
Chennai, Nov 13
Sun Pharma retreated from its morning highs near the close on Wednesday. However, it maintained its firm undertone to remain among the top gainers in midweek trading. At 2.45 p.m. it was quoting a...
Mumbai, Nov 8
Drug-maker Sun Pharma has said it is working with the Drug Controller General of India’s (DCGI) office on a concern recently raised by it involving Sun’s research facility in Mumbai. “Th...
Chennai, Oct 29
Sun Pharma was among the top gainers on both the BSE and NSE on Tuesday morning. At 10.55 a.m. it was quoting at Rs 613 on the BSE, up 1.52 per cent on its previous close of Rs 603.85.
October 28, 2013
Sun Pharmaceutical Industries Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 13, 2013, interalia, to consider and take on record the un-audite...
October 3, 2013
Sun Pharmaceutical Industries Ltd has submitted to BSE a copy of the report of the proceedings of the 20th Adjourned Annual General Meeting (AGM) of the Company held on September 30, 2013.
Mumbai, Sept 26
Market-cap up over 5 times since March 2008